FDA Plans For Private-Payer Meetings Ahead, But Roadblocks Remain
This article was originally published in The Gray Sheet
Executive Summary
FDA’s device center is recruiting private payers to meet with manufacturers during the pre-submission process to hasten reimbursement. But some experts believe the effort may be hobbled by a lack of common interests.